Narcolepsy with cataplexy, characterized by sleepiness and rapid onset into REM sleep, affects
1 in 2,000 individuals 1 , 2 . Narcolepsy was first shown to be tightly associated with HLA-…

Growing evidence supports the hypothesis that narcolepsy with cataplexy is an autoimmune
disease. We here report genome-wide association analyses for narcolepsy with replication …

… Collection of European samples was partly supported through EU-NN and UCB Pharma
grants to M Tafti. French sample collection was funded by PHRC 07-0138 Narcobank grant, by …

SLEEP, Vol. 33, No. 11, 2010 1429 Letter to the Editor—Dauvilliers et al lay between onset
and diagnosis is often long, 1, 13 more cases are likely to be identified in the future. How …

Study Objectives: To compare clinical, electrophysiologic, and biologic data in narcolepsy
without cataplexy with low (≤ 110 pg/ml), intermediate (110–200 pg/ml), and normal (> 200 pg…

Study Objective: To report on symptoms and therapies used in childhood narcolepsy-cataplexy.
Design, Patients, and Setting: Retrospective series of 51 children who completed the …

Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors
include pandemic 2009 H1N1 influenza A infection and immunization with Pandemrix®. Here…

Type 1 narcolepsy, a disorder caused by a lack of hypocretin (orexin), is so strongly
associated with human leukocyte antigen (HLA) class II HLA-DQA1 ∗ 01:02-DQB1 ∗ 06:02 (DQ0602…

Intestinal fatty acid binding protein (I-FABP) is an intracellular epithelial protein in the intestinal
mucosa of many animals. I-FABP appears in the circulation following epithelial damage, …

Narcolepsy, a disorder strongly associated with human leukocyte antigen (HLA)–DQA1*01:02/DQB1*06:02
(DQ0602), is characterized by excessive daytime sleepiness, cataplexy, and …